/Investor DB

Sonder Capital — 2025 Investments

5 investments dated 2025 · listed companies and verified rows first · show all

Cordance Medicalcordancemedical.comin𝕏Nov 2025

Cordance Medical develops medical technology focused on diagnosing and treating patients with brain diseases, drawing on expertise from neurosurgery, neuroimaging, and biomedical engineering.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtechMedical DevicesMountain View, US

Ryan Dittamore(CEO)in

Co-investorsAngel Physicians FundBeresford VenturesBlack Mountain VentuesCreative Destruction Lab (CDL)Samsung NextShanda Group+3 more

ForSight Roboticsforsightrobotics.comSeries B · Jun 2025 · $130M

ForSight Robotics develops the JASPER robotic surgery platform, combining robotics, advanced visualization, and AI-driven data analytics to assist ophthalmic surgeons in performing eye surgery.

AI & Machine LearningMedical DevicesRobotics

Daniel Glozman(Founder)Joseph Nathan(Founder)Moshe Shoham(Founder)

Co-investorsEclipse VenturesMithril Capital Management

Jupiterjupiter.coinOct 2025

Jupiter operates an advertising and e-commerce platform focused on the food, grocery, and CPG sector, positioning itself as an "AppLovin for food & CPG." The company serves brands and retailers in the food and beverage industry.

AdTechCreator EconomyE-commerceEnterprise SoftwareFoodTechMarketing TechMarketplacesNew York City, US

Chad Munroe(Founder/CEO)inNathan H. Leung(Engineer)inAnuraag NallapatiAnna PiñolWill YinSipra Roy Halteman(Careers Login)

Co-investorsY CombinatorCathexis VenturesGaingelsNFXSprint VcThe MBA Fund+9 more

Jupiter Bioventuresjupiter.bioinOct 2025

Jupiter is a biotech company that discovers and develops new medicines across multiple therapeutic areas.

BiotechChapel Hill, US

Ned Sharpless(Co-founder & CEO)Leigh Delacy(Co-founder & Partner and COO)

Co-investorsEshelman Ventures, LLCMission Biocapital3one4 CapitalBEENEXTHummingbird VenturesLB Investment+2 more

Petal Surgicalpetal.healthSeries A · Oct 2025 · $10M

Petal is developing an incisionless surgery platform using Millisecond Pulse Histotripsy, a form of focused therapeutic ultrasound that breaks down targeted diseased tissue without incisions, heat, or trauma.

BiotechDeep TechHealthtechMedical DevicesRedwood City, US

Prash Chopra(Founding CEO & Director)Bowen Jiang(Co-founder)Nicholas Theodore(Co-founder & Director)Prashant Chopra(Executive Officer, Director, Promoter)

BoardFrederic Moll(Director)inRony Abovitz(Co-founding Advisor)

Co-investorsShangBay Capital LLCTSVCDolma VenturesK50 Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.